Beth Diane Kirkpatrick

University of Vermont

NIH Rank #2653
  • Program Leader
  • Early Career

NIH Funding · FY2024

Total Funding
$3M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#2,653
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $3M across 4 grants · National rank #2653.

Top grants by award amount

Beth Diane Kirkpatrick's NIH grant portfolio, ranked by award amount.

  • 5U01AI134582-05U01
    A Phase II Evaluation of the Safety and Protective Efficacy of the Live Attenuated Tetravalent Dengue Vaccine TetraVax-DV with Challenge by the Recombinant DENV-2 Virus in a Dengue Endemic Population
    $1.2M
    award amount
  • 3P20GM125498-07S1P20
    Translational Research to Prevent and Control Global Infectious Diseases(Translational Global Infectious Diseases Research Center, TGIR)
    $956.4K
    award amount
  • 2U01AI141997-06U01
    Mechanisms of Protection and Durability for a Live Attenuated Tetravalent Dengue Vaccine
    $635.9K
    award amount
  • 5P20GM125498-07P20
    Translational Global Infectious Diseases Research Center
    $160.1K
    award amount

Affiliation

Institutions that have administered grants for Beth Diane Kirkpatrick.

Affiliated with University of Vermont (VT).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Vermont
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2653
  6. 2024
    Entered Top 25% Nationally
    Ranked #2653